Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence
What Is the Growth Potential of the Human Organoids Market Size Over 2025-2034?
The human organoids market size has grown rapidly in recent years. It will grow from $1.47 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to increasing focus on personalized medicine, a rise in the prevalence of chronic diseases, growth in regenerative medicine, expansion of drug discovery applications, and increasing government and private funding.
The human organoids market size is expected to see rapid growth in the next few years. It will grow to " $3.12 billion in 2029 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to growing demand for organoid-based disease modeling, rising investment in biotech research, expanding applications in drug screening, increasing adoption in toxicology studies, and growing interest in precision medicine. Major trends in the forecast period include integration with artificial intelligence, development of patient-specific organoids, expansion into gene therapy applications, advancements in organoid bioprinting, and technological progress in 3D cell culture.
Get your free report sample today:
What Are the Primary Factors Driving the Human Organoids Market?
The rising number of experiments in genetic science is expected to drive the growth of the human organoids market going forward. Genetic science is the branch of biology that studies how traits are inherited through genes and how genetic information influences the development and function of living organisms. The number of experiments in genetic science is rising due to technological breakthroughs that make gene editing faster and more precise. It enables deeper research into diseases and the development of targeted treatments. Genetic science benefits human organoids by allowing accurate manipulation of genes to model specific diseases and study their development. It helps researchers understand genetic disorders, test new drugs, and explore personalized treatment strategies more effectively. For instance, in April 2023, according to a report by the National Institutes of Health (NIH), a US-based medical research agency, as of November 2022, the U.S. had 129,624 registered genetic tests, representing approximately 66% of all tests submitted to the Genetic Testing Registry (GTR) worldwide. Therefore, the rising number of experiments in genetic science will drive the human organoids market.
Which Segments Are Likely to Shape the Future Outlook of the Human Organoids Market?
The human organoidsmarket covered in this report is segmented –
1) By Type: Brain Organoids; Heart Organoids; Intestinal Organoids; Kidney Organoids; Liver Organoids; Lung Organoids; Pancreatic Organoids
2) By Technology: 3D Bioprinting; Cell Culture Technology; Hydrogels And Scaffold-Based Technology; Magnetic Levitation
3) By Application: Drug Discovery; Infectious Disease Research; Neurology Studies; Oncology Research; Personalized Medicine; Regenerative Medicine
4) By End User: Pharma And Biotech Companies; Contract Research Organizations; Academic And Research Institutes
Subsegments:
1) By Brain Organoids: Cerebral Organoids; Midbrain Organoids; Hypothalamic Organoids; Spinal Cord Organoids
2) By Heart Organoids: Cardiac Muscle Organoids; Vascularized Heart Organoids; Chamber-Specific Heart Organoids
3) By Intestinal Organoids: Small Intestine Organoids; Colon Organoids; Duodenal Organoids
4) By Kidney Organoids: Nephron Organoids; Glomerular Organoids; Proximal Tubule Organoids
5) By Liver Organoids: Hepatic Organoids; Bile Duct Organoids; Cholangiocyte Organoids
6) By Lung Organoids: Airway Organoids; Alveolar Organoids; Bronchial Organoids
7) By Pancreatic Organoids: Islet Organoids; Ductal Pancreatic Organoids; Acinar Pancreatic Organoids
What Are the Current Trends Influencing the Human Organoids Market?
Major companies operating in the human organoids market are focusing on developing innovative stem cell technologies, such as next-generation 3D tissue culture platforms, to enhance the physiological relevance of in vitro models. A next-generation 3D tissue culture platform refers to an advanced in vitro system designed to mimic the complexity of human tissues more accurately than traditional 2D or earlier 3D models. For instance, in October 2022, AIM Biotech Pte. Ltd., a Singapore-based developer of tissue culture chips, introduced organiX, an advanced 3D tissue culture system designed to replicate human disease conditions more accurately by combining organoids, functional vasculature, and immune cell components. Tailored for cutting-edge drug development and personalized medicine, the platform accommodates various tissue formats, such as organoids and tumor samples, within a controllable and physiologically relevant setting. It supports immune co-culture, allows real-time high-resolution imaging, and facilitates effortless tissue retrieval for downstream analyses.
Which Key Players Dominate the Human Organoids Market Landscape?
Major companies operating in the human organoids market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Corning Incorporated, Bio-Techne Corporation, Organovo Holdings Inc., Emulate Inc., MIMETAS B.V., Cellink AB, InSphero AG, Kerafast Inc., DefiniGEN Limited, Visikol Inc., CN Bio Innovations Limited, Cannex Scientific Inc., HeartBeat.bio AG, Kirkstall Ltd., Cyprio Ltd., 3Dnamics Inc., BrainZell Ltd., AIVITA Biomedical Inc.
Get the detailed human organoids market report today
Which Region Is Expected to Dominate the Human Organoids Market During the Forecast Period?
North America was the largest region in the human organoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human organoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment